(Q39173608)

9 September 2017

Neurological complications of Behçet's syndrome (English)

1 reference

9 September 2017

0 references

D P Kidd

1

1 reference

9 September 2017

10 March 2017

1 reference

9 September 2017

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-017-8436-9

9 September 2017

0 references

cites work

Behçet's syndrome: disease manifestations, management, and advances in treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Uveitis in Behçet disease: an analysis of 880 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Therapy of ocular Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic review and meta-analyses of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Neuro-Behçet's disease: epidemiology, clinical characteristics, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Optic neuropathy in Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Cerebral venous thrombosis in Behçet's disease: clinical study and long-term follow-up of 25 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Cerebral venous thrombosis in Behçet's disease: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Neurological complications of Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Histopathology of central nervous system lesions in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Behçet's disease: diagnostic and prognostic aspects of neurological involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Prevalence and patterns of neurological involvement in Behcet's disease: a prospective study from Iraq

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Neurological manifestations of Behçet's disease in Japan: a study of 54 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Mass-like lesions as a rare form of neuro-Behçet's disease: A case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Neuropsychological follow-up of 12 patients with neuro-Behçet disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Cognitive impairment in Behçet's disease patients without overt neurological involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Cognitive functioning in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Neuro-Behçet's disease involving the pons with initial onset of affective symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

A case study of neuro-psycho-Behçet's syndrome presenting with psychotic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Neuro-Behçet disease presenting with acute psychosis in an adolescent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Epidemiology and management of neuropsychiatric disorders in Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Fatigue in patients with Behcet's syndrome: relationship with quality of life, depression, anxiety, disability and disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

The prevalence of headache in Behçet's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Headache in Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

New therapeutic solutions for Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Treatment of retinal vasculitis in Behçet's disease with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Rituximab is effective in severe treatment-resistant neurological Behçet's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Tocilizumab for severe refractory neuro-Behçet: three cases IL-6 blockade in neuro-Behçet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

Biological treatments in Behçet's disease: beyond anti-TNF therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8436-9

The natural course and factors affecting severity of Behçet's disease: a single-center cohort of 368 patients

21 January 2018

1 reference

12 December 2020

Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome

1 reference

12 December 2020

Neuro-Behçet's disease.

1 reference

12 December 2020

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients

1 reference

12 December 2020

Vascular involvement in Behçet's syndrome: a retrospective analysis of associations and the time course

1 reference

12 December 2020

Magnetic resonance imaging of vein wall thickness in patients with Behçet's syndrome.

1 reference

12 December 2020

Headache in Behçet's syndrome

1 reference

12 December 2020

Neurological complications in Behçet's syndrome

1 reference

12 December 2020

Long-term Efficacy of Interferon in Severe Uveitis Associated with Behçet Disease.

1 reference

12 December 2020

Thrombosis and Behçet's syndrome in non-endemic regions

1 reference

12 December 2020

Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases

1 reference

12 December 2020

10.1007/S00415-017-8436-9

Identifiers

DOI

1 reference

9 September 2017

1 reference

PubMed ID

28283819